U.S. Pharma Stock News

In March 2026, Neurocrine Biosciences presented new expert consensus recommendations and fresh INGREZZA (valbenazine) data on older adults with tardive dyskinesia at the PALTC26 conference in Anaheim, highlighting care challenges in long-term care settings. The company underscored INGREZZA’s differentiated clinical profile for seniors, including no required dose titration and a sprinkle formulation, alongside patient-reported improvements in symptoms, quality of life and functional...

Booking Holdings (NasdaqGS:BKNG) announces a 25-for-1 forward stock split, effective April 2, 2026. The company pairs the split with a higher dividend, changing both share count and cash returns to shareholders. The split is described as a historic move for Booking Holdings, aimed at widening access for retail investors. Booking Holdings operates a global online travel platform that connects consumers with accommodation, flights, and other travel services. The travel sector has been shaped...

Sam's Club, owned by Walmart, is raising membership prices and accelerating new U.S. store openings. Walmart Mexico is rolling out EdgeSense connected store technology across its operations to modernize stores and improve in store execution. These moves highlight Walmart's focus on membership driven revenue and technology enabled retail across different regions. For investors watching NasdaqGS:WMT, these updates sit alongside a share price of $124.28 and a 39.7% return over the past year...

The Morning Bull - US Market Morning Update Wednesday, Apr, 1 2026 US stock futures are pointing higher this morning, with E mini S&P 500 contracts up about 0.5% and Nasdaq 100 futures rising roughly 0.7%, as investors react to cooler bond markets and mixed global growth signals. The US 10 year Treasury yield is at 4.28%, which means borrowing costs are still relatively high but not pushing higher, easing some pressure on rate sensitive areas like real estate and smaller companies. At the...

We can readily understand why investors are attracted to unprofitable companies. For example, Annexon ( NASDAQ:ANNX...

Earnings results bring Precigen’s 2025 performance into focus Precigen (PGEN) recently reported full year 2025 results, with revenue of US$9.68 million and a net loss of US$250.64 million. The wider loss and revenue figures are likely central to how investors reassess the stock. See our latest analysis for Precigen. Precigen’s share price has been volatile, with a 1 day share price return of 19.08% and 7 day return of 23.64%, while the 90 day return shows a decline of 7.42%. This contrasts...

Creative Medical Technology Holdings, Inc. ( NASDAQ:CELZ ) is possibly approaching a major achievement in its business...

Potential LENZ Therapeutics, Inc. ( NASDAQ:LENZ ) shareholders may wish to note that the President, Evert...

The market seemed underwhelmed by the solid earnings posted by Adobe Inc. ( NASDAQ:ADBE ) recently. Along with the...

Market forces rained on the parade of MeiraGTx Holdings plc ( NASDAQ:MGTX ) shareholders today, when the analysts...

Camtek Ltd. recently announced it received a multi-system order worth US$31 million from a leading OSAT for CoWoS-like packaging geared toward AI applications, bringing first-quarter 2026 OSAT orders to over US$90 million, with systems scheduled for delivery within this year. This surge in advanced packaging demand from outsourced assembly and test providers highlights Camtek’s growing role in inspection and metrology for AI-focused semiconductor manufacturing workflows. Next, we’ll assess...

Jefferies Financial Group (JEF) is back on investors’ radar after a recent share price move, with the stock closing at $41.27. The company’s broader performance profile gives useful context for that reaction. See our latest analysis for Jefferies Financial Group. The latest move to $41.27 comes after a 4.11% 1-day share price return. This sits against a 30-day share price decline of 7.05% and a year-to-date share price return of negative 34.97%, while the 5-year total shareholder return of...

Lennox International (LII) moved higher after reports that President Trump was considering ending the military conflict in Iran, along with stabilizing oil prices that eased worries about energy costs and industrial disruptions. See our latest analysis for Lennox International. Lennox’s 4.54% 1 day share price gain to US$464.13 follows improving sentiment around conflict risks and energy costs. However, this comes after an 18.57% 30 day share price decline and a 16.79% 1 year total...

Recently, Southern Copper outlined a long-term plan to invest nearly US$19.90 billion over the next decade to lift copper production toward about 1.6 million tons annually by 2035, even as it anticipates near-term output pressure from weaker ore grades at its Peruvian mines. This commitment highlights how one of the industry’s largest reserve holders is positioning itself to be a major future supplier of copper-intensive, energy-transition materials. We’ll now examine how Southern Copper’s...

Why Allstate stock is on investors’ radar today Allstate (ALL) is drawing fresh attention after recent trading left the shares with a return of about flat over the past week and a roughly 3% decline over the past month. See our latest analysis for Allstate. At a share price of US$207.34, Allstate’s recent 3.4% 1 month share price decline comes against a steadier backdrop, with a 1.7% year to date share price return and a 5 year total shareholder return of 98.5% that may hint at mixed momentum...

Dutch Bros (BROS) is back in focus after reporting adjusted earnings per share of US$0.17 against forecasts of US$0.09, alongside record revenue and same store sales growth, while issuing cautious 2026 same store sales guidance. See our latest analysis for Dutch Bros. The share price reaction tells a mixed story, with a 1 day share price return of 5.56% after earnings but a year to date share price return of 18.50% decline, while the 3 year total shareholder return of 57.33% points to...

For investors wondering whether Amazon.com is fairly priced at around US$208 per share or if the market is missing something, this article explains what the current valuation signals may be indicating. The stock has been relatively flat over the past month with a 0.1% decline. It still shows a 6.3% return over the last year and a 106.0% return over three years, which may raise questions about whether the recent share price reflects its longer term performance. Recent headlines have focused...

Broadstone Net Lease (BNL) has drawn investor attention after recent share price moves, with the stock closing at $18.27 and showing mixed returns over the past week, month, and past 3 months. See our latest analysis for Broadstone Net Lease. While the 1 day and 1 month share price returns of 1.67% and 5.78% declines point to some cooling in the near term, the 90 day share price return of 5.18% and 1 year total shareholder return of 14.25% suggest momentum has built over a longer stretch as...

Why Waste Management’s renewable gas push matters now Waste Management (WM) is pouring billions into 20 renewable natural gas plants, a shift that puts regulatory trends, ESG mandates, and carbon credit markets in clearer focus as the upcoming earnings release approaches. See our latest analysis for Waste Management. Despite the upcoming earnings focus and the renewable gas build out, WM’s recent price action has been mixed, with a 4.6% 30 day share price decline but a 47.1% three year total...

Proto Labs (PRLB) is back in focus after reporting record quarterly revenue, 12.1% year over year revenue growth, and earnings that came in ahead of market expectations, along with guidance that topped EPS forecasts. See our latest analysis for Proto Labs. Despite the upbeat earnings news, Proto Labs has had a mixed share price run, with a 12.71% 90-day share price return and an 11.04% year-to-date share price return. The 1-year total shareholder return sits at 61.12% and the 3-year total...

If you are wondering whether Masimo at around US$177.87 is offering value or asking you to pay up for quality, this breakdown will help you frame that question clearly. The stock has been relatively steady over the last week with a 0.5% decline, modestly higher over 30 days with a 1.4% gain, and much stronger year to date with a 39.6% return, compared with a 6.1% return over the past year and a 24.2% decline over five years. Recent headlines have focused on Masimo's position in medical...

Volvo Cars has converted its outstanding shareholder loans to Polestar Automotive Holding UK (NasdaqGM:PSNY) into equity, changing the mix of Polestar’s capital structure. The two companies also agreed to concentrate future manufacturing of the Polestar 3 in the U.S., expanding their existing production collaboration. For investors watching NasdaqGM:PSNY, these moves come against a backdrop of a share price at $18.42 and a long term track record that includes a 41.5% decline over the past...

Terex stock: context for recent performance Terex (TEX) has drawn fresh attention after recent share price moves, with the stock up 0.8% over the past day, showing a 14% decline over the past month and a 10.7% gain over the past 3 months. See our latest analysis for Terex. That 7.7% 1 day share price return sits against a 14.1% 30 day share price decline and a 57.4% 1 year total shareholder return, which suggests momentum has cooled recently after a strong run for longer term holders. If...

Eli Lilly (NYSE:LLY) agreed to acquire Centessa Pharmaceuticals in a deal valued at up to US$7.8b. The transaction would expand Lilly’s neuroscience portfolio and add orexin receptor agonist candidates for sleep disorders such as narcolepsy and hypersomnia. This is Lilly’s largest announced deal since 2019 and marks its entry into the sleep disorder therapeutics market. Eli Lilly is widely associated with diabetes and obesity treatments, and this move highlights a push to build a broader...